Skip to main content
. Author manuscript; available in PMC: 2017 Jul 24.
Published in final edited form as: Hypertens Res. 2013 Oct 3;37(2):116–124. doi: 10.1038/hr.2013.129

Figure 4.

Figure 4

Hemodynamic changes after treatment with NPS2143 in hypoxia-induced pulmonary hypertension (HPH) mice. Representative traces (a) and summarized data (b) showing that NPS2143 attenuated the increase in right ventricular systolic pressure (RVSP). Representative traces (c) and summarized data (d) showing that NPS2143 attenuated the increase in ±dp/dtmax. *P<0.05 for Hypo +NPS2143 vs. Hypo. There were no significant differences in systemic blood pressure (SBP) between control mice with or without NPS treatment or between HPH mice with or without NPS treatment (e). A full color version of this figure is available at the Hypertension Research journal online.